T. Rowe Price Group's 15min Chart Triggers MACD and KDJ Death Cross.

As per T. Rowe Price Group's 15-minute chart, a MACD Death Cross and KDJ Death Cross have been observed at 13:00 on October 21, 2025. This suggests that the stock price has the potential to continue its downward trajectory, with momentum shifting towards the downside and a possibility of further price decrease.

As of October 21, 2025, T. Rowe Price Group's 15-minute chart indicates a MACD Death Cross and KDJ Death Cross for Talphera (TLPH) stock at 13:00. This technical analysis suggests a potential continuation of the stock's downward trajectory, with momentum shifting towards the downside and a possibility of further price decline Talphera Inc Stock Price, News & Analysis^[1].

Talphera Inc. (TLPH), a specialty pharmaceutical innovator, has been making significant strides in developing therapies for critical care environments. However, recent market indicators may signal a shift in investor sentiment. The MACD Death Cross and KDJ Death Cross are technical signals that often indicate a trend reversal, suggesting that the stock's downward momentum may continue Talphera Inc Stock Price, News & Analysis^[1].

In the past few months, Talphera has reported several key developments. The company has achieved a 17-patient enrollment milestone in its pivotal NEPHRO CRRT clinical trial, which is crucial for the second tranche of its March 2025 three-tranche financing agreement . Additionally, Talphera announced a private placement financing of up to $29 million, led by CorMedix Inc., which will support the company's planned Niyad PMA approval in H2 2026 .

Despite these positive developments, the technical indicators point towards a potential downward trend. Investors should closely monitor the stock's performance and remain vigilant about any further announcements from Talphera. The company's ongoing clinical trials and financial results will continue to influence the stock's trajectory.